![Dose Tapering and Discontinuation of Biological Therapy in Rheumatoid Arthritis Patients in Remission in Routine Care – 2-Year Outcomes and Identification of Predictors](http://www.ia-grp.com/wp-content/plugins/revslider/public/assets/assets/transparent.png)
![](http://www.ia-grp.com/wp-content/uploads/2017/07/ORANGE-SLIDER-SHAPE-1.1.png)
Dose Tapering and Discontinuation of Biological Therapy in Rheumatoid Arthritis Patients in Remission in Routine Care – 2-Year Outcomes and Identification of Predictors
Published:
June 20, 2018
Publication:
Annals of the Rheumatic Diseases
Authors:
C.H. Brahe, S. Krabbe, M. Østergaard, L. Ørnbjerg, D. Glinatsi, H. Røgind, H.S. Jensen, A. Hansen, J. Nørregaard, S. Jacobsen, L. Terslev, T.K. Huynh, D.V. Jensen, N. Manilo, K. Asmussen, P.B. Frandsen, M. Boesen, Z. Rastiemadabadi, L.M. Carlsen, J. Møller, N.S. Krogh, M.L. Hetland